Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate

被引:30
作者
Kudryashov, V
Ragupathi, G
Kim, IJ
Breimer, ME
Danishefsky, SJ
Livingston, PO
Lloyd, KO
机构
[1] Mem Hosp, Program Immunol, New York, NY 10021 USA
[2] Mem Hosp, Mol Pharmacol & Therapeut Program, Sloan Kettering Inst, New York, NY 10021 USA
[3] Mem Hosp, Clin Immunol Serv, New York, NY 10021 USA
[4] Gothenburg Univ, Sahlgrenska Univ Hosp, Dept Surg, Gothenburg, Sweden
关键词
monoclonal antibody; globo H; synthetic oligosaccharides; tumor antigen; glycolipid;
D O I
10.1023/A:1006992911709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Globo H (Fuc alpha 1-->2Gal beta 1-->3GalNAc beta 1-->3Gal alpha 1-->4Gal beta 1-->4Glc) is a carbohydrate structure that shows enhanced expression in many human carcinomas. From mice immunized with a globo H-KLH (keyhole limpet hemocyanin) synthetic conjugate an IgG3 monoclonal antibody (mAb VK-9) was derived that recognizes the globo H structure. Serological analysis showed that the minimal structure recognized by this mAb was the tetrasaccharide sequence Fuc alpha 1-->2Gal beta 1-->3Gal-NAc beta 1-->3Gal. An isomeric structure with an internal alpha GalNAc linkage was also recognized but less efficiently. mAb VK-9 did not react with many related structures, such as galactosylgloboside, globoside, H type 1, H type 2 blood group structures or fucosyl-gangliotetraosyl ceramide, but did react weakly with globo A ceramide. Not only did mAb VK-9 react with carbohydrate-protein conjugates but it could also recognize globo H-ceramide and human tumor cells expressing globo H. These results suggest that globo H-KLH could be explored as a vaccine in the treatment of carcinoma patients.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 35 条
[1]   TOTAL SYNTHESIS OF A HUMAN BREAST-TUMOR ASSOCIATED ANTIGEN [J].
BILODEAU, MT ;
PARK, TK ;
HU, SH ;
RANDOLPH, JT ;
DANISHEFSKY, SJ ;
LIVINGSTON, PO ;
ZHANG, SL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (29) :7840-7841
[2]  
BREIMER ME, 1982, J BIOL CHEM, V257, P557
[3]   STRUCTURAL CHARACTERIZATION OF A BLOOD GROUP-A HEPTAGLYCOSYLCERAMIDE WITH GLOBO-SERIES STRUCTURE - THE MAJOR GLYCOLIPID BASED BLOOD GROUP-A ANTIGEN OF HUMAN-KIDNEY [J].
BREIMER, ME ;
JOVALL, PA .
FEBS LETTERS, 1985, 179 (01) :165-172
[4]  
BREMER EG, 1984, J BIOL CHEM, V259, P4773
[5]   RICIN-A CHAIN CONJUGATED WITH MONOCLONAL-ANTIBODIES SELECTIVELY KILLING HUMAN CARCINOMA-CELLS INVITRO [J].
CANEVARI, S ;
ORLANDI, R ;
RIPAMONTI, M ;
TAGLIABUE, E ;
AGUANNO, S ;
MIOTTI, S ;
MENARD, S ;
COLNAGHI, MI .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1985, 75 (05) :831-839
[6]   REPETITIVE-A EPITOPE (TYPE-3 CHAIN-A) DEFINED BY BLOOD GROUP-A1-SPECIFIC MONOCLONAL-ANTIBODY TH-1 - CHEMICAL BASIS OF QUALITATIVE-A1 AND A2-DISTINCTION [J].
CLAUSEN, H ;
LEVERY, SB ;
NUDELMAN, E ;
TSUCHIYA, S ;
HAKOMORI, SI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (04) :1199-1203
[7]   BLOOD GROUP-A GLYCOLIPID (AX) WITH GLOBO-SERIES STRUCTURE WHICH IS SPECIFIC FOR BLOOD GROUP-A1 ERYTHROCYTES - ONE OF THE CHEMICAL BASES FOR A1 AND A2 DISTINCTION [J].
CLAUSEN, H ;
WATANABE, K ;
KANNAGI, R ;
LEVERY, SB ;
NUDELMAN, E ;
ARAOTOMONO, Y ;
HAKOMORI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (02) :523-529
[8]   APPLICATION OF THE GLYCAL ASSEMBLY METHOD TO THE CONCISE SYNTHESIS OF NEOGLYCOCONJUGATES OF LE(Y) AND LE(B) BLOOD-GROUP DETERMINANTS AND OF H-TYPE-I AND H-TYPE-II OLIGOSACCHARIDES [J].
DANISHEFSKY, SJ ;
BEHAR, V ;
RANDOLPH, JT ;
LLOYD, KO .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (21) :5701-5711
[9]   CELL-SURFACE ANTIGENS OF HUMAN-MALIGNANT MELANOMA - DEFINITION OF 6 ANTIGENIC SYSTEMS WITH MOUSE MONOCLONAL-ANTIBODIES [J].
DIPPOLD, WG ;
LLOYD, KO ;
LI, LTC ;
IKEDA, H ;
OETTGEN, HF ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10) :6114-6118
[10]   ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE [J].
EY, PL ;
PROWSE, SJ ;
JENKIN, CR .
IMMUNOCHEMISTRY, 1978, 15 (07) :429-436